Albert Bourla, Founder of Pfizer

Albert Bourla is the founder of Pfizer. He became CEO in January 2019 and has focused on transforming Pfizer into a science-driven company.

About Albert Bourla

Albert Bourla is the Chairman and Chief Executive Officer of Pfizer, a global biopharmaceutical company that discovers, develops, manufactures, markets, sells, and distributes biopharmaceutical products. He became CEO in January 2019 and has focused on transforming Pfizer into a science-driven company, increasing investment in R&D and technology. Under his leadership, Pfizer has made significant acquisitions, including Seagen in 2023 and Metsera in 2025, to advance its pipeline in oncology, internal medicine, inflammation and immunology, vaccines, and obesity and metabolic disease. He is also recognized for leading Pfizer's rapid development of a COVID-19 vaccine and antiviral treatment.

Albert Bourla at a glance

More founders in Thessaloniki, Greece (28)

Browse related founder lists (2)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades